QRG Capital Management Inc. Sells 626 Shares of Humana Inc. (NYSE:HUM)

QRG Capital Management Inc. decreased its holdings in shares of Humana Inc. (NYSE:HUM) by 22.6% during the 4th quarter, Holdings Channel reports. The firm owned 2,144 shares of the insurance provider’s stock after selling 626 shares during the quarter. QRG Capital Management Inc.’s holdings in Humana were worth $544,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Versor Investments LP boosted its holdings in shares of Humana by 120.6% during the 4th quarter. Versor Investments LP now owns 3,397 shares of the insurance provider’s stock worth $862,000 after buying an additional 1,857 shares in the last quarter. Heritage Oak Wealth Advisors LLC acquired a new position in shares of Humana during the 4th quarter valued at $2,342,000. Proficio Capital Partners LLC bought a new position in Humana during the fourth quarter worth $14,097,000. Oppenheimer & Co. Inc. grew its holdings in Humana by 17.2% in the fourth quarter. Oppenheimer & Co. Inc. now owns 3,313 shares of the insurance provider’s stock worth $841,000 after purchasing an additional 486 shares during the period. Finally, Mn Services Vermogensbeheer B.V. increased its stake in Humana by 1.7% in the fourth quarter. Mn Services Vermogensbeheer B.V. now owns 48,012 shares of the insurance provider’s stock valued at $12,181,000 after purchasing an additional 800 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

HUM has been the topic of a number of research analyst reports. JPMorgan Chase & Co. reduced their target price on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Barclays raised their price objective on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. Piper Sandler boosted their price objective on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Finally, Truist Financial boosted their price target on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Twenty equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, Humana presently has an average rating of “Hold” and an average price target of $285.68.

Humana Stock Performance

Shares of HUM opened at $263.74 on Wednesday. The stock has a 50 day moving average of $271.40 and a 200 day moving average of $285.08. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a market capitalization of $31.82 billion, a price-to-earnings ratio of 26.51, a PEG ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date is Friday, March 28th. Humana’s payout ratio is 35.58%.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.32% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.